Lakewood-Amedex Biotherapeutics Inc (LABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 03-2000 | 03-1999 | 03-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 236 | 681 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 2,020 | 1,580 | 170 |
| TOTAL | $305 | $774 | $2,020 | $1,580 | $170 |
| Non-Current Assets | |||||
| PPE Net | 9 | 14 | N/A | N/A | N/A |
| Other Non-Current Assets | 167 | 283 | 21,440 | 13,510 | 1,240 |
| TOTAL | $176 | $297 | $21,440 | $13,510 | $1,240 |
| Total Assets | $482 | $1,071 | $23,460 | $15,090 | $1,410 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 2,900 | 0 | N/A |
| Accounts payable and accrued liabilities | 381 | 167 | 9,410 | 8,490 | 1,490 |
| Accrued Expenses | 304 | 222 | 3,150 | 3,680 | N/A |
| Other current liabilities | N/A | N/A | 0 | 0 | 10 |
| TOTAL | $2,405 | $501 | $26,400 | $16,170 | $1,500 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 41 | 160 | 0 | 0 | 0 |
| TOTAL | $41 | $160 | $N/A | $N/A | $N/A |
| Total Liabilities | $2,446 | $661 | $26,400 | $16,170 | $1,500 |
| Shareholders' Equity | |||||
| Common Shares | 1 | 1 | 40 | 60 | N/A |
| Retained earnings | -53,351 | -49,504 | N/A | N/A | N/A |
| Other shareholders' equity | -147 | -147 | -40 | -50 | 0 |
| TOTAL | $-1,965 | $410 | $23,800 | $20,560 | $N/A |
| Total Liabilities And Equity | $482 | $1,071 | $50,200 | $36,730 | $1,500 |